Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 106
of 6Next
1:

A multidisciplinary approach for the treatment of GIST liver metastasis.

Radkani P, Ghersi MM, Paramo JC, Mesko TW.

World J Surg Oncol. 2008 May 9;6:46.

PMID: 18471285 [PubMed - indexed for MEDLINE]

2:

[A case of gastrointestinal stromal tumor with liver and bone metastases effectively treated with radiofrequency ablation and imatinib mesylate]

Ishikawa A, Teratani T, Ono S, Ochiai T, Kakinoki N, Kishimoto Y, Kamoshida T, Hirai S, Oka Y, Shimokama T.

Nippon Shokakibyo Gakkai Zasshi. 2006 Nov;103(11):1274-9. Japanese.

PMID: 17085910 [PubMed - indexed for MEDLINE]

3:

Cerebral relapse of metastatic gastrointestinal stromal tumor during treatment with imatinib mesylate: case report.

Hughes B, Yip D, Goldstein D, Waring P, Beshay V, Chong G.

BMC Cancer. 2004 Oct 9;4:74.

PMID: 15473910 [PubMed - indexed for MEDLINE]

4:

The clinical characteristics and the role of surgery and imatinib treatment in patients with liver metastases from c-Kit positive gastrointestinal stromal tumors (GIST).

Rutkowski P, Nyckowski P, Grzesiakowska U, Nowecki ZI, Nasierowska-Guttmejer A, Pienkowski A, Dudek K, Krawczyk M, Ruka W.

Neoplasma. 2003;50(6):438-42.

PMID: 14689066 [PubMed - indexed for MEDLINE]

5:

Disease progression following imatinib failure in gastrointestinal stromal tumors: role of surgical therapy.

Jamali FR, Darwiche SS, El-Kinge N, Tawil A, Soweid AM.

Oncologist. 2007 Apr;12(4):438-42.

PMID: 17470686 [PubMed - indexed for MEDLINE]

6:

[A case of Giant GIST of the stomach successfully treated with imatinib mesylate neoadjuvant therapy and followed postoperatively]

Okuda H, Tanaka H, Ueno M, Shitani M, Nasuno M, Suzuki C, Nishimura S, Kimura H, Yonezawa K, Abe T, Yoshida Y, Kawabata M.

Gan To Kagaku Ryoho. 2005 Nov;32(12):1941-4. Japanese.

PMID: 16282731 [PubMed - indexed for MEDLINE]

7:

Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours: systematic review and economic evaluation.

Wilson J, Connock M, Song F, Yao G, Fry-Smith A, Raftery J, Peake D.

Health Technol Assess. 2005 Jul;9(25):1-142. Review.

PMID: 15985189 [PubMed - indexed for MEDLINE]

8:

[A long-term survival case with multiple liver metastases from duodenal gastrointestinal stromal tumor that was drastically reduced by the treatment with imatinib]

Sakakura C, Miyagawa K, Fukuda K, Kin S, Nakase Y, Kuriu Y, Nakashima S, Yoshikawa T, Yamaoka N, Sagara Y, Hagiwara A, Yamagishi H.

Gan To Kagaku Ryoho. 2005 Oct;32(11):1739-41. Japanese.

PMID: 16315926 [PubMed - indexed for MEDLINE]

10:

[Recommendations for the management of GIST patients]

Blay JY, Landi B, Bonvalot S, Monges G, Ray-Coquard I, Duffaud F, Bui NB, Bugat R, Chayvialle JA, Rougier P, Bouché O, Bonichon F, Lassau N, Vanel D, Nordlinger B, Stoeckle E, Meeus P, Coindre JM, Scoazec JY, Emile JF, Ranchère D, Le Cesne A.

Bull Cancer. 2005 Oct 1;92(10):907-18. French.

PMID: 16266874 [PubMed - indexed for MEDLINE]

11:

Surgical resection of gastrointestinal stromal tumors after treatment with imatinib.

Andtbacka RH, Ng CS, Scaife CL, Cormier JN, Hunt KK, Pisters PW, Pollock RE, Benjamin RS, Burgess MA, Chen LL, Trent J, Patel SR, Raymond K, Feig BW.

Ann Surg Oncol. 2007 Jan;14(1):14-24.

PMID: 17072676 [PubMed - indexed for MEDLINE]

12:

Two cases of complete response after imatinib mesylate treatment of advanced GIST.

Papaxoinis G, Nikolaou M, Lianos E, Gaglia A, Economopoulos T, Pectasides D.

Anticancer Res. 2006 Nov-Dec;26(6C):4869-72.

PMID: 17214353 [PubMed - indexed for MEDLINE]

13:

[Successful treatment of huge peritoneal metastasis from duodenal gastrointestinal stromal tumor resistant for imatinib mesylate]

Sakakura C, Kumano T, Mizuta Y, Yamaoka N, Sagara Y, Hagiwara A, Otsuji E.

Gan To Kagaku Ryoho. 2007 Nov;34(12):2144-6. Japanese.

PMID: 18219926 [PubMed - indexed for MEDLINE]

14:

Gastrointestinal stromal tumor: 5 years later.

van der Zwan SM, DeMatteo RP.

Cancer. 2005 Nov 1;104(9):1781-8. Review.

PMID: 16136600 [PubMed - indexed for MEDLINE]

15:

Management of gastrointestinal stromal tumors in the imatinib era: selected case studies.

Benjamin RS, Blanke CD, Blay JY, Bonvalot S, Eisenberg B.

Oncologist. 2006 Jan;11(1):9-20. Review.

PMID: 16401709 [PubMed - indexed for MEDLINE]

16:

Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO.

Blay JY, Bonvalot S, Casali P, Choi H, Debiec-Richter M, Dei Tos AP, Emile JF, Gronchi A, Hogendoorn PC, Joensuu H, Le Cesne A, McClure J, Maurel J, Nupponen N, Ray-Coquard I, Reichardt P, Sciot R, Stroobants S, van Glabbeke M, van Oosterom A, Demetri GD; GIST consensus meeting panelists.

Ann Oncol. 2005 Apr;16(4):566-78. Review. Erratum in: Ann Oncol. 2005 Jun;16(6):993. Mac Clure, J [corrected to McClure, J].

PMID: 15781488 [PubMed - indexed for MEDLINE]

17:

Effect of imatinib (STI571) on metastatic gastrointestinal stromal tumors: report of a case.

Ando Y, Tsunoda T, Beck Y, Takayama T, Tahara H.

Surg Today. 2005;35(2):157-60.

PMID: 15674500 [PubMed - indexed for MEDLINE]

18:

Pathological complete response in advanced gastrointestinal stromal tumor after imatinib therapy.

Melichar B, Voboril Z, Nozicka J, Ryska A, Urminská H, Vanecek T, Michal M.

Intern Med. 2005 Nov;44(11):1163-8.

PMID: 16357454 [PubMed - indexed for MEDLINE]

19:

Imatinib mesylate induces responses in patients with liver metastases from gastrointestinal stromal tumor failing intra-arterial hepatic chemotherapy.

Fiorentini G, Bernardeschi P, Rossi S, Dentico P, Biancalani M, Giustarini G, Turrisi G.

J Cancer Res Ther. 2006 Apr-Jun;2(2):68-71.

PMID: 17998678 [PubMed - indexed for MEDLINE]

20:

Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors.

Rutkowski P, Debiec-Rychter M, Nowecki ZI, Wozniak A, Michej W, Limon J, Siedlecki JA, Jerzak Vel Dobosz A, Grzesiakowska U, Nasierowska-Guttmejer A, Sygut J, Nyckowski P, Krawczyk M, Ruka W.

Med Sci Monit. 2007 Nov;13(11):CR515-522.

PMID: 17968300 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 106
of 6Next